123330 — Genic Co Income Statement
0.000.00%
Last trade - 00:00- KR₩24bn
- KR₩29bn
- KR₩28bn
Annual income statement for Genic Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 43,151 | 42,132 | 38,408 | 31,449 | 28,070 |
| Cost of Revenue | |||||
| Gross Profit | 7,180 | 9,096 | 6,918 | 2,699 | 3,234 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 44,297 | 41,092 | 42,352 | 34,977 | 32,093 |
| Operating Profit | -1,147 | 1,040 | -3,944 | -3,528 | -4,023 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -712 | 30.9 | -4,199 | -3,340 | -4,411 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -712 | 30.9 | -4,199 | -3,340 | -4,411 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -11,959 | -4,353 | -4,331 | -3,340 | -4,411 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -11,959 | -4,353 | -4,331 | -3,340 | -4,411 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -107 | 2.12 | -613 | -436 | -643 |
| Dividends per Share |